A study on protection of astragaioside IV about oxidative stress on PC12 cells induced by H2O2

Chinese Pharmacological Bulletin

Volumn 27, Issue 11, 2011, Pages 1603-1609

  Wang, Shi Bo ^a   Qiu, Jing Fu ^b   Bai, Qun Hua ^b   Li, Jia Jia ^a   He, Jin Yu ^b   Gao, Yan Jun ^c   Yu, Chao ^a  

^a Institute of Life Science   (China)

^b School of Public Health   (China)

^c Faculty of Pharmacy and Medical Laboratory   (China)

Author keywords

Astragaioside IV; Cyclin A; Cyclin D1; Oxidative stress; PC12 cell

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; 4 [5 (4 METHYL 1 PIPERAZINYL)[2,5' BI 1H BENZIMIDAZOL] 2' YL]PHENOL; ANTIOXIDANT; ASTRAGAIOSIDE IV; CYCLIN A; CYCLIN D1; HYDROGEN PEROXIDE; NUCLEIC ACID; REACTIVE OXYGEN METABOLITE; SYNAPTOPHYSIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL CYCLE; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL PROTECTION; CELL STRAIN; CELL VIABILITY; FLOW CYTOMETRY; OXIDATIVE STRESS; PROTEIN EXPRESSION; WESTERN BLOTTING;

EID: 84862916583     PISSN: 10011978     EISSN: None     Source Type: Journal    
DOI: 10.3969/j.issn.1001-1978.2011.11.031     Document Type: Article

References (17)

1. Filosto M, Scarpelli M, Cotelli M S, et al. The role of mitochondria in neurodegenerative diseases[J]. J Neurol, 2011 May 22. http://www.ncbi.nlm.nih. gov/pubmed/21604203.
2. Martin L J. Neuronal cell death in nervous system development, disease, and injury[J]. Int J Mol Med, 2001,7(5):455-78.
3. Matus S, Glimcher L H, Hetz C. Protein folding stress in neurodegenerative diseases:a glimpse into the ER[J]. Curr Opin Cell Biol, 2011,23(2):239-52.
4. Salminen A, Kauppinen A, Suuronen T, et al. ER stress in Alzheimer's disease:a novel neuronal trigger for inflammation and Alzheimer's pathology[J]. J Neuroinflammation, 2009,6(41). http:// www.jneuroinflammation.com/content/6/1/ 41.
5. Ienco E C, LoGerfo A, Carlesi C, et al. Oxidative stress treatment for clinical trials in neurodegenerative diseases[J]. J Alzheimer's Dis, 2011,24:111-26.
6. Wu F B, Chen X Y. Review of pharmacological properties of astragalus[J]. J Chin Med Materials, 2004,27(3):232-4.
7. Chai L J, Zhong P R, Zhang Y J, et al. Proliferation effects of asteagaloside on neural atem cells in vitro [J]. Chin Pharmacol Bull, 2010,26(5):610-3.
8. Ji X J, Li A, Duan M L, Zhang S W. A study on protection and mechanism of astragaioside IV on monocytes stimulated by lipopolysaccharide [J]. Chin J TCM WM Crit Care, 2010,17(5):271-3.
9. Pan J, Chen S D. Oxidative stress and neurodegenerative disease [J]. J Intern Neurol Neuros, 2008,35(2):143-5.
10. 2 in PC12 cell: Mechanism via MMP, ROS, and Bcl-2[J]. Brain Res, 2005,1057(2):57-64.
11. Rubin L L, Philpott K L, Brooks S F. Apoptosis : the cell cycle and cell death[J]. Curr Biol, 1993,3(6):391-4.
12. Stacey D W. Cyclin D1 selves as a cell cycle regulatory switch iactively proliferating cells [J]. Curr Opin Cell Biol, 2003,15(2):158-63. (Pubitemid 36332190)
13. Simile M M, Miglio M R, Muroni M R, et al. Down-regulation of cmyc and Cyclin D1 genes by antisense oligodeoxy nucleotides inhibits the expression of E2F1 and in vitro growth of HepG2 ang Morris 5123 liver cancer cells [J]. Carcinogenesis, 2004,25(3):333-441.
14. Fernandes D J, Ravenhall C E, Harris T, et al. Contribution of the p38MAPK signalling pathway to proliferation in human cultured airway smooth muscle cells is mitogen-specific[J]. Br J Pharmacol, 2004,142:1182-90. (Pubitemid 39093015)
15. Engel F B, Schebesta M, Duong M T, et al. p38 MAP kinase inhibition enables proliferation of adult mammalian cardiomyocytes [J]. Genes Dev, 2005,19(10):1175-87. (Pubitemid 40696184)
16. Ju Y H, Yu A M, Xie Z H, Sun X H. Glucosamine inhibits activation of HUVEC induced by LL-37[ J]. Pro Anatomical Sci, 2010,16(3):226-9.
17. Yang T N, Jiang Y Q, Yu C, et al. Chitosan oligosaccharides suppress interleukin-6 and interleukin-8 production in vascular endothelial cells EA. hy926 induced by TNF-α via increasing p38MAPK protein O-GlcNAc modification [J]. Chin Pharmacol Bull, 2011,27(2):252-7.